Side-by-side comparison of AI visibility scores, market position, and capabilities
Jacksonville Class I eastern US railroad (NASDAQ: CSX) ~$14.5B 2024 revenue; PSR operating model, new CEO Steve Angel (Sept 2025, ex-Linde), 20,000 route miles competing with Norfolk Southern for eastern freight.
CSX Corporation is a Jacksonville, Florida-based Class I freight railroad — publicly traded on NASDAQ (NASDAQ: CSX) as an S&P 500 Industrials component — operating approximately 20,000 route miles across 26 states in the eastern United States and two Canadian provinces, connecting industrial facilities, ports, agricultural markets, intermodal terminals, and power plants through approximately 22,000 employees. CSX transports merchandise freight (chemicals, automotive, agricultural products, metals, food), intermodal containers and trailers, and coal (utility coal to power plants and export coal to terminals) across the densest rail network in the eastern US, including critical connections to the Port of Baltimore, Port of Savannah, and Port of Norfolk. In fiscal year 2024, CSX reported revenue of approximately $14.5 billion, with the Precision Scheduled Railroading (PSR) operating model maintaining operating ratio efficiency while managing volume volatility from coal headwinds and intermodal competition. A defining leadership development is the September 28, 2025 appointment of Steve Angel as President and CEO, succeeding Joe Hinrichs — Angel brings two decades of operational experience from Linde plc (where he served as CEO from 2018 to 2022 and oversaw the $90B Linde-Praxair merger) and 22 years at General Electric working directly with locomotive and rail operations, bringing a manufacturing and industrial operations discipline to CSX's continued operational improvement agenda.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.